Bluejay Net Income From Continuing Ops from 2010 to 2024

BJDX Stock  USD 3.75  0.23  6.53%   
Bluejay Diagnostics Net Loss yearly trend continues to be fairly stable with very little volatility. Net Loss is likely to outpace its year average in 2024. During the period from 2010 to 2024, Bluejay Diagnostics Net Loss regression line of annual values had significance of  0 and arithmetic mean of (2,780,992). View All Fundamentals
 
Net Loss  
First Reported
2010-12-31
Previous Quarter
-10 M
Current Value
-9.5 M
Quarterly Volatility
3.6 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Bluejay Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bluejay Diagnostics' main balance sheet or income statement drivers, such as Net Interest Income of 173.1 K, Depreciation And Amortization of 820 K or Interest Expense of 22.8 K, as well as many indicators such as Price To Sales Ratio of 1.2 K, Dividend Yield of 0.0 or PTB Ratio of 24.26. Bluejay financial statements analysis is a perfect complement when working with Bluejay Diagnostics Valuation or Volatility modules.
  
Check out the analysis of Bluejay Diagnostics Correlation against competitors.
For more information on how to buy Bluejay Stock please use our How to Invest in Bluejay Diagnostics guide.

Latest Bluejay Diagnostics' Net Income From Continuing Ops Growth Pattern

Below is the plot of the Net Income From Continuing Ops of Bluejay Diagnostics over the last few years. It is Bluejay Diagnostics' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bluejay Diagnostics' overall financial position and show how it may be relating to other accounts over time.
Net Income From Continuing Ops10 Years Trend
Slightly volatile
   Net Income From Continuing Ops   
       Timeline  

Bluejay Net Income From Continuing Ops Regression Statistics

Arithmetic Mean(2,780,992)
Coefficient Of Variation(129.77)
Mean Deviation2,831,228
Median(819,842)
Standard Deviation3,608,833
Sample Variance13T
Range9.2M
R-Value(0.75)
Mean Square Error6T
R-Squared0.57
Significance0
Slope(608,535)
Total Sum of Squares182.3T

Bluejay Net Income From Continuing Ops History

2024-9.5 M
2023-10 M
2022-9.3 M
2021-3.5 M
2020-1.2 M

About Bluejay Diagnostics Financial Statements

Bluejay Diagnostics investors use historical fundamental indicators, such as Bluejay Diagnostics' Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Bluejay Diagnostics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Loss-10 M-9.5 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Bluejay Stock Analysis

When running Bluejay Diagnostics' price analysis, check to measure Bluejay Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bluejay Diagnostics is operating at the current time. Most of Bluejay Diagnostics' value examination focuses on studying past and present price action to predict the probability of Bluejay Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bluejay Diagnostics' price. Additionally, you may evaluate how the addition of Bluejay Diagnostics to your portfolios can decrease your overall portfolio volatility.